Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,182.9
33.6 (1.07%)

 

  • STI Straits Times Index
    3,182.9
    33.6 (1.07%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,491.3
    -8.9 (-0.60%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,426.5
    231.7 (0.88%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,477.2
    29.2 (0.85%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,584.1
    -57.8 (-0.21%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,159.0
    28.5 (0.46%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,254.2M
  • Value: 1,485.3M
  • Rise: 188
  • Fall: 133
  • Unch: 439

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.123+0.001
Intl Cement0.027+0.001
Genting Sing0.800-
GKE0.146+0.002
China Star Food0.029+0.004
YZJ Shipbldg SGD1.430+0.040
Golden Agri-Res0.240+0.005
Jiutian Chemical0.085+0.002
Rex Intl0.245+0.010
Keppel Reit1.120-0.010

World Indices

World Indices
Name Last Change
Nasdaq 14,761.3 +80.2
HSI 26,426.5 +231.7
HSCEI 9,419.2 +98.9
Jakarta 6,159.0 +28.5
Nikkei 225 27,584.1 -57.8
SSE Comp 3,477.2 +29.2
Shanghai A 3,644.4 +30.6
Shanghai B 260.0 +2.6
KOSPI 3,280.4 +43.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GEMINI THERAPEUTIC GEMINI THERAPEUTICS
Updated on 03 Aug 2021 (End of trading day)
Last (USD): 3.890 Change: -0.290 High: 4.265 Remarks: -
Change (%): -6.94 Low: 3.850
Open 4.265 Yesterday's Close 4.18
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 219,656 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.01890 Trailing EPS (USD) e -0.46189 NAV (USD) b 3.9806
PE a - Trailing PE f - Price / NAV b 0.9772
Dividend (USD) d - Cash In Hand (USD) g 4.3021 Issued & Paid-up Shares c 42,998,700
Dividend Yield (%) d - Price / Cash In Hand g 0.904 Treasury Shares h -
Market Cap (M) 167.265 Enterprise Value (M) -8.592
Piotroski F Score - Exchange Code GMTX Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 45.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 08 Feb 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GEMINI THERAPEUTIC NASDAQ 167.265 - - 0.9772 -
Industry Biotechnology NASDAQ 3,075.659 106.306 106.381 7.4394 0.545
Local Peer MODERNA INC NASDAQ 155,194.587 - 259.451 40.4363 -
Local Peer AMGEN INC NASDAQ 140,237.140 19.306 19.794 15.0244 2.639
Local Peer GILEAD SCIENCES INC NASDAQ 87,566.820 711.897 16.964 4.4428 3.895
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 84,969.503 4,904.642 58.459 28.6934 -
Local Peer ILLUMINA INC NASDAQ 72,769.320 110.929 115.507 14.7845 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 62,489.104 17.787 15.607 5.2174 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 51,786.143 19.098 26.001 5.6311 -
Local Peer BIOGEN INC NASDAQ 50,373.154 12.591 26.262 4.6850 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 31,543.458 - - 7.8785 -
Local Peer SEAGEN INC NASDAQ 28,780.139 46.898 48.186 8.4865 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 21,018.221 - - 22.6931 -
Local Peer 10X GENOMICS INC NASDAQ 19,604.665 - - 26.0543 -
Other Local Peers BIO-TECHNE CORP (NASDAQ), EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EXELIXIS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARVINAS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ALECTOR INC (NASDAQ), INSTIL BIO INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SEER INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MAXCYTE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MACROGENICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), MIMEDX GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), OCUGEN INC (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), BIOATLA INC (NASDAQ), UNIQURE N.V. (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALLOVIR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), FIBROGEN INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), AGENUS INC (NASDAQ), PRECIGEN INC (NASDAQ), VAXCYTE INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NKARTA INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), VAXART INC (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), OMEROS CORP (NASDAQ), HUMANIGEN INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), IVERIC BIO INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), IMMUNOVANT INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), SESEN BIO INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CHIMERIX INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), COMPUGEN (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VOR BIOPHARMA INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), GERON CORP (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), ATHIRA PHARMA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), ALTIMMUNE INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ATHERSYS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), BIOVIE INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AVROBIO INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ATRECA INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), NEXTCURE INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), IN8BIO INC (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), IMMUNOME INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), HCW BIOLOGICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EQUILLIUM INC (NASDAQ), ARDELYX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CONTRAFECT CORP (NASDAQ), SYNLOGIC INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ENSYSCE BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CYTOCOM INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGENESIS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), IMV INC (NASDAQ), INFLARX N V (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LONGEVERON INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), BON NAT LIFE LTD (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), METACRINE INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTAMIRA THERAPEUTICS LTD (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HISTOGEN INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), TRANSCODE THERAPEUTICS INC (NASDAQ), PALISADE BIO INC (NASDAQ), ADITX INC (NASDAQ), ZIVO BIOSCIENCE INC (NASDAQ), GEOVAX LABS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 133,025.104 42.414 34.953 12.5883 1.004
Global Peer WUXI BIO HKEx 550,208.355 289.922 289.921 22.5660 -
Global Peer BEIGENE HKEx 244,418.616 - - 7.8526 -
Global Peer SINO BIOPHARM HKEx 129,964.655 41.737